Indeed, by blocking osteoclasts, ZOL inhibits the release of growth factor (TGF-β, IGF-1...) trapped in bone matrix and liberated during bone resorption to activate proliferation of tumor cells. The gene discussed is IGF1; the disease is neoplasm.